Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trial

Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trial

Abstract Background Children hospitalised with severe anaemia in malaria endemic areas in Africa are at high risk of readmission or death within 6 months post-discharge. Currently, no strategy specifically addresses this period. In Malawi, 3 months of post-discharge malaria chemoprevention (PMC) wit...

Full description

Bibliographic Details
Main Authors: Titus K. Kwambai, Aggrey Dhabangi, Richard Idro, Robert Opoka, Simon Kariuki, Aaron M. Samuels, Meghna Desai, Michael Boele van Hensbroek, Chandy C. John, Bjarne Robberstad, Duolao Wang, Kamija Phiri, Feiko O. ter Kuile
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Trials
Subjects:
Malaria
Severe anaemia
Chemoprevention
Post-discharge
Readmission
Mortality
Online Access:http://link.springer.com/article/10.1186/s13063-018-2972-1

Internet

http://link.springer.com/article/10.1186/s13063-018-2972-1

Similar Items